Search results
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 14 hours ago"That said, Novavax's vaccine has demonstrated strong protection to date, and we will be interested...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi By Investing.com
Investing.com· 2 days agoThe deal, which includes upfront and milestone payments of around $1.3 billion, half of which is...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
WKBN 27 Youngstown· 5 days agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, has entered into a co-exclusive licensing agreement with Sanofi ...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 4 days agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Novavax Inc.’s record one-day gain is forcing some short sellers betting against the...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 2 days ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Trending tickers: Anglo American, GameStop, Vodafone, Greggs and Novavax
Yahoo Finance UK· 20 hours agoNovavax signed a $1.2bn licensing agreement with Sanofi that includes commercialising a combined...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 2 days agoJust when the Covid-vaccine maker Novavax Inc.'s (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the license deal with Sanofi ...